53 related articles for article (PubMed ID: 1248416)
1. [Weight reduction and glucose intolerance in obese subjects (author's transl)].
Berger M; Baumhoff E; Gries FA
Dtsch Med Wochenschr; 1976 Feb; 101(9):307-11. PubMed ID: 1248416
[TBL] [Abstract][Full Text] [Related]
2. [Massive obesity with disturbance of glucose tolerance (author's transl)].
Toeller M; Gries FA; Shleppinghoff B; Berger M; Dannehl K
Dtsch Med Wochenschr; 1979 Oct; 104(43):1513-7. PubMed ID: 498973
[TBL] [Abstract][Full Text] [Related]
3. [Weight reduction and sugar deprivation in glucose tolerance disturbance. A two-year study of 131 normal and overweight subjects (author's transl)].
Schimmler W; Schuderer A; Kurz M
MMW Munch Med Wochenschr; 1976 Nov; 118(46):1481-4. PubMed ID: 825766
[TBL] [Abstract][Full Text] [Related]
4. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
[TBL] [Abstract][Full Text] [Related]
5. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
Van Gaal L
Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
[TBL] [Abstract][Full Text] [Related]
6. Diffuse idiopathic skeletal hyperostosis in diabetes mellitus, impaired glucose tolerance and obesity.
Coaccioli S; Fatati G; Di Cato L; Marioli D; Patucchi E; Pizzuti C; Ponteggia M; Puxeddu A
Panminerva Med; 2000 Dec; 42(4):247-51. PubMed ID: 11294086
[TBL] [Abstract][Full Text] [Related]
7. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
[TBL] [Abstract][Full Text] [Related]
8. Long-term influences of body-weight changes, independent of the attained weight, on risk of impaired glucose tolerance and Type 2 diabetes.
Black E; Holst C; Astrup A; Toubro S; Echwald S; Pedersen O; Sørensen TI
Diabet Med; 2005 Sep; 22(9):1199-205. PubMed ID: 16108849
[TBL] [Abstract][Full Text] [Related]
9. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of glucose intolerance in school age children. Population based cross-sectional study.
Mazur A; Grzywa M; Małecka-Tendera E; Telega G
Acta Paediatr; 2007 Dec; 96(12):1799-802. PubMed ID: 17953725
[TBL] [Abstract][Full Text] [Related]
11. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
Mohan V; Shanthirani CS; Deepa R
J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
[TBL] [Abstract][Full Text] [Related]
12. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
Ko GT; Cockram CS; Chan JC
J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
[TBL] [Abstract][Full Text] [Related]
13. Metabolic abnormalities in first-degree relatives of type 2 diabetics.
Di Pietro S; Suraci C
Boll Soc Ital Biol Sper; 1990 Jul; 66(7):631-8. PubMed ID: 2083058
[TBL] [Abstract][Full Text] [Related]
14. [Studies of insulinemia in obese patients].
Jakubczyk D
Rocz Akad Med Bialymst (1989); 1990-1991; 35-36():21-42. PubMed ID: 2136545
[TBL] [Abstract][Full Text] [Related]
15. Metabolic characteristics of glucose intolerance: the critical role of obesity.
Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
[TBL] [Abstract][Full Text] [Related]
16. [Oral glucose tolerance tests--with or without estimation of serum insulin? (author's transl)].
Haupt E; Petzoldt R; Probst S; Schöffling K
Dtsch Med Wochenschr; 1981 Jun; 106(25):798-803. PubMed ID: 7016491
[TBL] [Abstract][Full Text] [Related]
17. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
[TBL] [Abstract][Full Text] [Related]
18. Gender modulates the relationship between body weight and plasma glucose in overweight or obese subjects.
Seghieri G; Tesi F; Anichini R; De Bellis A; Fabbri G; Malagoli R; Franconi F
Diabetes Res Clin Pract; 2008 Apr; 80(1):134-8. PubMed ID: 18077049
[TBL] [Abstract][Full Text] [Related]
19. [Raised plasma glucagon levels in obesity (author's transl)].
Starke A; Starke G; Jörgens V; Berger M; Zimmermann H
Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1125-8. PubMed ID: 7084079
[TBL] [Abstract][Full Text] [Related]
20. [The cardiovascular risk-profile of persons with normal, borderline disturbed and certain pathological glucose tolerance in dependence on the body-weight (author's transl)].
Schneider H; Ziegelasch HJ
Z Alternsforsch; 1981; 36(3):227-33. PubMed ID: 7293260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
